Back to Agenda
Session 5: OPDP Research Update
Session Chair(s)
Kathryn Aikin, PhD, MS
Senior Social Science Analyst, Research Team Lead, OPDP, CDER
FDA, United States
Catherine Gray, PharmD
Director, Office of Prescription Drug Promotion, OMP, CDER
FDA, United States
Individual FDA/OPDP researchers will present findings from OPDP research studies. Attendees will get an overview of the FDA/OPDP Research program and how it may contribute to knowledge, guidance, and policy development in the prescription drug advertising and promotion space.
Pre-recorded session, no live Q&A
Learning Objective : At the conclusion of this session, participants should be able to:
- Describe the holistic research agenda of FDA/OPDP
- Identify the individual topic areas of study and how they fit together
- Restate some results of recent research
Speaker(s)
Research Status Update
Kathryn Aikin, PhD, MS
FDA, United States
Senior Social Science Analyst, Research Team Lead, OPDP, CDER
Character-Space-Limited Online Prescription Drug Communications: Four Experimental Studies
Helen W. Sullivan, PhD, MPH
FDA, United States
Social Science Analyst, OPDP, OMP, CDER
Disease Awareness and Prescription Drug Communications on Television: Evidence for Conflation and Misleading Product Impressions
Kevin R. Betts, PhD
FDA, United States
Social Science Analyst, OPDP, OMP, CDER
How Physicians View Data of Uncertain Clinical Utility in Oncology Prescription Drug Promotion
Amie O'Donoghue, PhD
FDA, United States
Social Science Analyst, OPDP, OMP, CDER
Have an account?